Fibrocell Science Inc.

Fibrocell, a cell and gene therapy company, is focused on diseases affecting the skin and connective tissue. Our approach to personalized biologics is distinctive based on our proprietary autologous fibroblast technology. By extracting fibroblast cells from a patient’s own skin, we create localized gene therapies that are compatible with the unique biology of each patient and have the potential to address the underlying cause of disease.To be a leader in creating personalized biologics that have the potential to transform the lives of patients and the future of medicine.

Bank Name Fibrocell Science Inc.
Stock Exchange NASDAQ
Symbol FCSC
Sector Healthcare
Industry Major Pharmaceuticals
Country United States
World Region America
CEO Mr. John Michael Maslowski
Employees 20
Registered Year 1992